• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前对颌骨骨坏死病理生理学的认识。

Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.

机构信息

Department of Periodontology, University of Florida College of Dentistry, Gainesville, FL, 32610, USA.

Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, 1011 North University Ave, Ann Arbor, MI, 48109, USA.

出版信息

Curr Osteoporos Rep. 2018 Oct;16(5):584-595. doi: 10.1007/s11914-018-0474-4.

DOI:10.1007/s11914-018-0474-4
PMID:30155844
Abstract

PURPOSE OF REVIEW

Osteonecrosis of the jaw (ONJ) is a rare and severe necrotic bone disease reflecting a compromise in the body's osseous healing mechanisms and unique to the craniofacial region. Antiresorptive and antiangiogenic medications have been suggested to be associated with the occurrence of ONJ; yet, the pathophysiology of this disease has not been fully elucidated. This article raises the current theories underlying the pathophysiology of ONJ.

RECENT FINDINGS

The proposed mechanisms highlight the unique localization of ONJ. The evidence-based mechanisms of ONJ pathogenesis include disturbed bone remodeling, inflammation or infection, altered immunity, soft tissue toxicity, and angiogenesis inhibition. The role of dental infections and the oral microbiome is central to ONJ, and systemic conditions such as rheumatoid arthritis and diabetes mellitus contribute through their impact on immune resiliency. Current experimental studies on mechanisms of ONJ are summarized. The definitive pathophysiology is as yet unclear. Recent studies are beginning to clarify the relative importance of the proposed mechanisms. A better understanding of osteoimmunology and the relationship of angiogenesis to the development of ONJ is needed along with detailed studies of the impact of drug holidays on the clinical condition of ONJ.

摘要

目的综述

颌骨骨坏死(ONJ)是一种罕见且严重的骨坏死疾病,反映了机体骨愈合机制的失调,且仅发生于颅面区域。有研究提示抗吸收和抗血管生成药物与 ONJ 的发生相关,但该病的发病机制尚未完全阐明。本文提出了 ONJ 发病机制的现有理论。

最近的发现

提出的机制强调了 ONJ 的独特定位。ONJ 发病机制的循证机制包括骨改建紊乱、炎症或感染、免疫改变、软组织毒性和血管生成抑制。牙感染和口腔微生物组在 ONJ 中起核心作用,而类风湿关节炎和糖尿病等系统性疾病则通过其对免疫弹性的影响而发挥作用。总结了 ONJ 发病机制的当前实验研究。确切的发病机制尚不清楚。最近的研究开始阐明所提出的机制的相对重要性。需要更好地了解骨免疫学以及血管生成与 ONJ 发展的关系,还需要详细研究药物停药对 ONJ 临床状况的影响。

相似文献

1
Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.当前对颌骨骨坏死病理生理学的认识。
Curr Osteoporos Rep. 2018 Oct;16(5):584-595. doi: 10.1007/s11914-018-0474-4.
2
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
3
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
4
Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.接受骨靶向治疗患者的颌骨骨坏死:概述——第一部分
Urol Nurs. 2016 May-Jun;36(3):111-6, 154.
5
[Osteonecrosis of the jaw].[颌骨骨坏死]
Endokrynol Pol. 2011;62 Suppl 3:4-9.
6
Bisphosphonate-associated osteonecrosis of the jaw: patient care considerations: overview for the orthopaedic nursing healthcare professional.
Orthop Nurs. 2010 May-Jun;29(3):176-80; quiz 181-2. doi: 10.1097/NOR.0b013e3181dcd2a2.
7
Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.小鼠发生颌骨骨坏死:口腔黏膜屏障免疫中由γδ T细胞调节的疾病变体
J Biol Chem. 2015 Jul 10;290(28):17349-66. doi: 10.1074/jbc.M115.652305. Epub 2015 May 26.
8
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.颌骨骨坏死的诊断和治疗:系统评价和国际共识。
J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405.
9
Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?双膦酸盐相关的颌骨坏死是由软组织毒性引起的吗?
Bone. 2007 Sep;41(3):318-20. doi: 10.1016/j.bone.2007.04.196. Epub 2007 May 10.
10
Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.颌骨骨坏死与双膦酸盐相关 - 特征、危险因素、临床特征、定位及对肿瘤治疗的影响。
J Craniomaxillofac Surg. 2012 Jun;40(4):303-9. doi: 10.1016/j.jcms.2011.05.003. Epub 2011 Jun 14.

引用本文的文献

1
Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients.抗吸收药物相关性颌骨坏死:癌症患者中的发病率及预防措施应用情况
Saudi Dent J. 2024 Dec;36(12):1635-1640. doi: 10.1016/j.sdentj.2024.12.005. Epub 2024 Dec 5.
2
Osteonecrosis of the external auditory canal in two patients on denosumab therapy.两名接受地诺单抗治疗的患者发生外耳道骨坏死。
JBMR Plus. 2025 Aug 18;9(10):ziaf134. doi: 10.1093/jbmrpl/ziaf134. eCollection 2025 Oct.
3
Autologous Platelet Concentrates in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review.

本文引用的文献

1
The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.阿仑膦酸盐和拔牙对骨质疏松患者颌骨坏死发生率的影响。
PLoS One. 2018 Apr 25;13(4):e0196419. doi: 10.1371/journal.pone.0196419. eCollection 2018.
2
Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.用地诺单抗替代唑来膦酸是发生颌骨坏死的一个危险因素。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):547-551. doi: 10.1016/j.oooo.2018.02.010. Epub 2018 Mar 6.
3
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.
自体血小板浓缩物在药物相关性颌骨坏死治疗中的应用:一项系统评价
Medicina (Kaunas). 2025 Aug 21;61(8):1496. doi: 10.3390/medicina61081496.
4
Medication-related osteonecrosis of the jaws: a series of 22 cases highlighting their histopathological features.药物相关性颌骨骨坏死:22例病例系列研究,重点突出其组织病理学特征
Braz Oral Res. 2025 Jun 2;39:e058. doi: 10.1590/1807-3107bor-2025.vol39.058. eCollection 2025.
5
Supra-Physiological Levels of Magnesium Counteract the Inhibitory Effect of Zoledronate on RANKL-Dependent Osteoclastogenesis.超生理水平的镁可抵消唑来膦酸对RANKL依赖性破骨细胞生成的抑制作用。
Biology (Basel). 2025 May 11;14(5):533. doi: 10.3390/biology14050533.
6
Peri-implant inflammation increases the risk of osteonecrosis in mice treated with bisphosphonate.种植体周围炎症增加了用双膦酸盐治疗的小鼠发生骨坏死的风险。
J Periodontol. 2025 Apr 15. doi: 10.1002/JPER.24-0760.
7
The Microbiological Background of Medication-Related Osteonecrosis of the Jaw (MRONJ): Clinical Evidence Based on Traditional Culture and Molecular Biological Detection Methods.颌骨药物相关性骨坏死(MRONJ)的微生物学背景:基于传统培养和分子生物学检测方法的临床证据
Antibiotics (Basel). 2025 Feb 15;14(2):203. doi: 10.3390/antibiotics14020203.
8
Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.药物相关性颌骨坏死的遗传背景:当前证据和未来展望。
Int J Mol Sci. 2024 Sep 29;25(19):10488. doi: 10.3390/ijms251910488.
9
Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw.自体血小板浓缩物作为颌骨药物相关性骨坏死外科治疗的辅助手段
Periodontol 2000. 2025 Feb;97(1):287-307. doi: 10.1111/prd.12608. Epub 2024 Sep 30.
10
Application of bone perforation in the surgery of medication-related osteonecrosis of the jaw in stage Ⅱ.骨穿孔在Ⅱ期药物相关性颌骨坏死手术中的应用。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2024 Oct 1;42(5):629-635. doi: 10.7518/hxkq.2024.2024133.
地舒单抗停药后发生的椎体骨折:一项 FREEDOM 随机安慰剂对照试验及其延伸的事后分析。
J Bone Miner Res. 2018 Feb;33(2):190-198. doi: 10.1002/jbmr.3337. Epub 2017 Nov 22.
4
Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis.唑来膦酸对实验性牙周炎拔牙后牙槽窝愈合的影响。
J Dent Res. 2018 Mar;97(3):312-320. doi: 10.1177/0022034517732770. Epub 2017 Sep 27.
5
Tissue-Specific Immunity at the Oral Mucosal Barrier.口腔黏膜屏障的组织特异性免疫。
Trends Immunol. 2018 Apr;39(4):276-287. doi: 10.1016/j.it.2017.08.005. Epub 2017 Sep 8.
6
Micrometer-Sized Magnesium Whitlockite Crystals in Micropetrosis of Bisphosphonate-Exposed Human Alveolar Bone.双膦酸盐暴露的人牙槽骨微石病中的微米级大小的镁白磷钙石晶体。
Nano Lett. 2017 Oct 11;17(10):6210-6216. doi: 10.1021/acs.nanolett.7b02888. Epub 2017 Sep 18.
7
Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB.唑来膦酸通过抑制破骨细胞形成和血小板衍生生长因子-BB(PDGF-BB)的分泌来抑制血管生成和成骨作用。
PLoS One. 2017 Jun 8;12(6):e0179248. doi: 10.1371/journal.pone.0179248. eCollection 2017.
8
Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity.唑来膦酸对体内骨重建和体外 BMSCs 成骨活性的骨骼部位特异性影响。
Sci Rep. 2017 Jan 31;7:36129. doi: 10.1038/srep36129.
9
The starting point for bisphosphonate-related osteonecrosis of the jaw: Alveolar bone or oral mucosa? A randomized, controlled experimental study.双膦酸盐相关颌骨坏死的起始点:牙槽骨还是口腔黏膜?一项随机对照实验研究。
J Craniomaxillofac Surg. 2017 Jan;45(1):157-161. doi: 10.1016/j.jcms.2016.10.015. Epub 2016 Nov 2.
10
Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect.唑来膦酸和依替膦酸对拔牙窝和胫骨缺损骨愈合的差异调节作用
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jan;123(1):8-19. doi: 10.1016/j.oooo.2016.08.009. Epub 2016 Aug 18.